Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France
- 29 June 2001
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 4 (2) , 124-131
- https://doi.org/10.1038/sj.pcan.4500517
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- THE IMPACT OF MEDICAL THERAPY ON BOTHER DUE TO SYMPTOMS, QUALITY OF LIFE AND GLOBAL OUTCOME, AND FACTORS PREDICTING RESPONSEJournal of Urology, 1998
- Pharmacotherapy for benign prostatic hyperplasia — the potential for α1‐adrenoceptor subtype‐specific blockadePublished by Wiley ,1998
- Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1998
- A multicentric, placebo‐controlled, double‐blind clinical trial of β‐sitosterol (phytosterol) for the treatment of benign prostatic hyperplasiaBritish Journal of Urology, 1997
- Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patientsThe Prostate, 1996
- Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trialsUrology, 1996
- Letter to the EditorThe Prostate, 1996
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasiaThe Lancet, 1995
- Results of an Epidemiological Survey Using a Modified American Urological Association Symptom Index for Benign Prostatic Hyperplasia in FranceJournal of Urology, 1994